Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic

J Gen Intern Med. 2021 Jun;36(6):1829-1831. doi: 10.1007/s11606-021-06660-5. Epub 2021 Mar 19.

Authors

Ryan K McBain¹, Jonathan H Cantor², Anupam B Jena^{3

4}, Megan F Pera⁵, Dena M Bravata⁵, Christopher M Whaley²

Affiliations

¹ RAND Corporation, Boston, MA, USA. rmcbain@mail.harvard.edu.
² RAND Corporation, Santa Monica, CA, USA.
³ Harvard Medical School, Boston, MA, USA.
⁴ Massachusetts General Hospital, Boston, MA, USA.
⁵ Castlight Health, San Francisco, CA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

COVID-19*
Early Detection of Cancer
Humans
Neoplasms*
Pandemics
SARS-CoV-2

Grants and funding